"Immunotherapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection.
| Descriptor ID |
D007167
|
| MeSH Number(s) |
E02.095.465.425
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunotherapy".
Below are MeSH descriptors whose meaning is more specific than "Immunotherapy".
This graph shows the total number of publications written about "Immunotherapy" by people in this website by year, and whether "Immunotherapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 4 | 4 | 8 |
| 1993 | 9 | 9 | 18 |
| 1994 | 14 | 9 | 23 |
| 1995 | 17 | 14 | 31 |
| 1996 | 8 | 9 | 17 |
| 1997 | 10 | 17 | 27 |
| 1998 | 16 | 20 | 36 |
| 1999 | 22 | 24 | 46 |
| 2000 | 14 | 15 | 29 |
| 2001 | 23 | 19 | 42 |
| 2002 | 83 | 81 | 164 |
| 2003 | 111 | 76 | 187 |
| 2004 | 103 | 104 | 207 |
| 2005 | 131 | 103 | 234 |
| 2006 | 122 | 104 | 226 |
| 2007 | 141 | 127 | 268 |
| 2008 | 166 | 127 | 293 |
| 2009 | 147 | 148 | 295 |
| 2010 | 204 | 139 | 343 |
| 2011 | 197 | 140 | 337 |
| 2012 | 177 | 155 | 332 |
| 2013 | 251 | 190 | 441 |
| 2014 | 282 | 224 | 506 |
| 2015 | 340 | 240 | 580 |
| 2016 | 448 | 305 | 753 |
| 2017 | 586 | 395 | 981 |
| 2018 | 614 | 385 | 999 |
| 2019 | 271 | 182 | 453 |
| 2020 | 83 | 58 | 141 |
| 2021 | 29 | 43 | 72 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunotherapy" by people in Profiles.
-
Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections. Appl Microbiol Biotechnol. 2021 Aug; 105(16-17):6315-6332.
-
Überantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines. JAMA. 2021 Aug 17; 326(7):589-590.
-
COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry. PLoS One. 2021; 16(7):e0255316.
-
Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across. Adv Drug Deliv Rev. 2021 09; 176:113900.
-
Editorial: Targets for Disease-Modifying Therapies in Alzheimer's Disease, Including Amyloid ß and Tau Protein. Med Sci Monit. 2021 Jul 26; 27:e934077.
-
A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation. J Exp Clin Cancer Res. 2021 Jul 23; 40(1):240.
-
The role of NK cells in fighting the virus infection and sepsis. Int J Med Sci. 2021; 18(14):3236-3248.
-
Treatment and prevention strategies for the COVID 19 pandemic: A review of immunotherapeutic approaches for neutralizing SARS-CoV-2. Int J Biol Macromol. 2021 Sep 01; 186:490-500.
-
Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors. J Immunother Cancer. 2021 07; 9(7).
-
Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors. J Immunother Cancer. 2021 07; 9(7).